Janssen launches Tecvayli in Egypt; A treatment for Multiple Myeloma, a type of bloodcCancer
Cairo – Janssen, the pharmaceutical arm of Johnson & Johnson and a leader in healthcare, has announced the launch of Tecvayli in the Egyptian market. This new treatment represents a significant advancement for patients suffering from multiple myeloma one of the most challenging and life-threatening types of blood cancer, accounting for 15% of all blood cancers and 1.9% of cancer-related deaths.
Janssen has invested over two decades in research and innovation in the field of multiple myeloma. As part of its ongoing commitment to delivering innovative and effective therapies to patients worldwide, the company continues to explore new treatment approaches for this serious and complex disease.
Dr. Ashraf El-Ghandour, Professor of Hematology and Internal Medicine at Alexandria University, stated, "Multiple myeloma is an aggressive and complex disease, often associated with several complications, including anemia, infections, peripheral neuropathy, kidney dysfunction, and bone fractures." He added, 'This underscores the critical role of advanced, modern therapies in the management of multiple myeloma. Consistent adherence to treatment is essential to maintaining a durable response, in alignment with international clinical guidelines.'
Dr. Raafat Abdel Fattah, Consultant Hematologist and Bone Marrow Transplant Specialist at the National Cancer Institute, Cairo University, stated, "Tecvayli is a targeted monotherapy for adult patients with relapsed and refractory multiple myeloma who have received at least three prior treatments. It acts on the BCMA receptor of cancer cells and is administered subcutaneously. This drug represents a significant advancement for blood cancer patients, especially those facing limited treatment options or who have relapsed after previous therapies or developed resistance to them."
Tecvayli specifically targets multiple myeloma cells, employing a mechanism that helps control the disease and its progression.
In this regard, Dr. Ahmed El-Houfi, Managing Director of Janssen Egypt, stated, "We strongly believe in the vital role played by Egypt's national institutions, working alongside private sector companies to bring the latest innovative treatments to patients at the right time. This is both a humanitarian and professional responsibility."
El-Houfi added, "In recent years, we have witnessed remarkable advancements in Egypt's healthcare sector, driven by the government's commitment to strengthening the pharmaceutical industry. These efforts include continuous engagement with the private sector and organizing key forums that bring together industry professionals to explore new avenues for development and ways to provide healthcare services at the highest global standards. We will continue our partnership with relevant stakeholders to ensure that this new hope reaches every patient in need."
Dr. Heba Hussein, Medical Director JENA at Janssen Egypt, stated, "The launch of Tecvayli in Egypt reflects our ongoing commitment to patients and reinforces our leadership role in providing advanced treatments for multiple myeloma, a type of blood cancer." She added, "Janssen has been at the forefront of multiple myeloma treatment since 2017."
Meanwhile, Dr. Mervat Mattar, Professor of Hematology at Qasr Al-Aini, said, "The introduction of Tecvayli in Egypt marks a significant step in delivering advanced and effective treatment solutions, particularly for patients experiencing relapse or resistance to therapy. We are dedicated to ensuring these innovative treatments reach those in greatest need, leading to tangible improvements in their quality of life."
Dr. Mattar further emphasized, "Egypt's healthcare sector is committed to providing the latest innovations and treatments available worldwide to Egyptian patients. This aligns with Egypt's Vision 2030 and is facilitated through collaboration and partnerships with global pharmaceutical companies, foremost among them Johnson & Johnson, which played a pivotal role in today's launch event."
Notably, Janssen has been improving patients' lives for over 60 years through innovation, expertise, and strategic partnerships. In the field of oncology specifically, the company has consistently led global efforts to reduce the burden of disease and provide breakthrough treatments that make a real difference.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
12 hours ago
- Zawya
Counting days to recovery, Yusuf opens up about his painful journey with mpox
When Yusuf Sesay first noticed a strange itch around his genital area, mpox wasn't the first thing that came to mind. He figured it might just be a mild infection, something a quick pharmacy run could fix. But within a few days, the discomfort spiralled into something harder to ignore: fever, pounding headaches, and the kind of fatigue that made getting out of bed quite difficult. Yet, he kept self-medicating, hoping it would go away. 'I was embarrassed,' he says quietly. 'I didn't think it was serious at first. Then I became scared.' Yusuf is one of over 3,600 people in Sierra Leone who have tested positive for mpox since the start of 2025. But numbers alone don't capture what it's like to live through it. The physical pain, the emotional toll, the fear of being judged. Sitting on a hospital chair in one of Freetown's mpox treatment centres, he's ready to share his story. 'It started with itching. Down there,' he says, not making eye contact at first. 'I thought it was just a regular infection. Something I could treat with meds from the pharmacy. But the symptoms didn't stop. The itching got worse.' 'I was scared,' he says, 'and ashamed. I told the woman I slept with that she had given me something. She said it wasn't from her. I didn't know what to believe. So I just kept quiet and and tried to fix it myself.' By the time he arrived at the treatment centre, he was exhausted, physically, mentally, emotionally. The sores had worsened. He knew he needed help. 'I feel a lot better now,' he says. 'The treatment is working. The health workers have been amazing. They respect and care for us. They don't judge.' There are four mpox treatment centres in Freetown. The centre where Yusuf is recovering is one of them and like the others, it is receiving support from the World Health Organization, which has been working closely with the government of Sierra Leone since the outbreak began. 'In close collaboration with the Ministry of Health and partners, we are working to break the chain of transmission and safeguard lives.' – Dr George Ameh, WHO Country Representative. WHO is helping to strengthen the mpox response, from delivering medical supplies and equipment to providing technical guidance and supporting community engagement. 'We are gratful to the health workers, who are taking good care of us.' He speaks calmly, openly. No hesitation. He knows people outside still doubt that mpox is real. Some think it's a hoax. While others believe it only affects a certain class of people. 'Let me tell you something,' Yusuf says, his voice a little firmer now. 'Mpox is real. I've lived it. I am still living it. If you notice any signs, don't wait. Don't be like me. Go to the hospital early. It makes a huge difference.' Since January, Sierra Leone has reported more than 3,600 confirmed cases of mpox. And behind each number is someone like Yusuf, with a similar story. 'Stay safe. Wash your hands. Protect yourself. Don't be careless. What I am going through now… I could have avoided it if I had gone to the hospital earlier.' During WHO's recent visit to the centre, Yusuf didn't hesitate to speak to the team, where he shared his story, answered questions and assured the team he's ready to help raise awareness, so others don't go through the same thing. 'I want to help. Even if it's just talking to people. If hearing my story helps one person stay safe, then it's worth it.' In a time when stigma and misinformation can keep people from seeking care or speaking up, Yusuf's honesty is refreshing and will save lives. Distributed by APO Group on behalf of World Health Organization - Sierra Leone.
Zawya
19 hours ago
- Zawya
Digital health solutions for non-communicable disease care in Zimbabwe
Sharing data in real time to make critical health care decisions Connecting rural and remote communities to Zimbabwe 's primary health system used to include delays of up to one month and loads of paperwork. Now, with the support of UNICEF and partners, the Ministry of Health and Child Care has equipped Village Health Workers with data-driven tools to make timely and lifesaving health care decisions. Digital health solutions like the use of a smartphone to transmit patient data in real time have empowered these workers to improve outcomes for children living with non-communicable diseases. Village Health Workers, trained volunteers who provide essential health and nutrition services to families and children, often work in remote areas that have limited access to health facilities. In the past, they recorded patient notes during their rounds that were then shared with the public health system, often long after the visit. 'We used to compile reports in a book which we would submit at the clinic at the end of the month. Now it is smoother and faster. Cellphones have been a game-changer,' says 52-year-old Margaret Denhera, a Village Health Worker in Luwana, Zimbabwe. Village Health Workers in Zimbabwe receive regular training on the digital medical equipment and devices they use on their rounds. © UNICEF 'I move around the village collecting information on non-communicable diseases. At the end of the day, I punch it into my phone,' says Denhera. She sends the data to the nearest health facility about 10 miles away. As the front line in Zimbabwe's public health system, Village Health Workers are often the first to identify non-communicable diseases like high blood pressure, chronic respiratory illness, cancer and diabetes. These diseases disproportionately affect people in developing countries, leading to the death of nearly 1 million people under age 20 each year worldwide. In Zimbabwe, NCDs are on the rise. Non-communicable diseases: A growing burden on Zimbabwe's health system Many, but by no means all, NCDs are preventable and treatable with early intervention and education on risk factors like excessive alcohol, inactivity, poor nutrition and tobacco use. Left undetected and untreated, NCDs can rapidly become life-threatening. Village Health Workers educate families on these risky behaviors and are trained to detect and test for NCDs on their rounds. The prompt reporting of a patient's symptoms to the nearest health facility can save a child's life. 'Village health workers are our foot soldiers,' says Yemurai Chamburuka, a primary care nurse at Patchway Clinic. 'When they see patients with abnormalities, they can easily call us or send the data by phone. It is to our advantage because we have the information as early as possible rather than waiting until the end of the month,' she says. 'If, during my checkup rounds, I test someone and observe, say, abnormal blood glucose levels, which is a sign of some non-communicable diseases, I refer the person to the clinic and send their test results ahead,' Denhera explains. Clinic nurses can review the real-time data and develop an action plan before the patient even reaches the facility. Video: Digitizing health systems in Zimbabwe Because they come to know their clients and their environment so well, Village Health Workers often identify trends or potential disease outbreaks in their recordkeeping. The data they capture in real time is analyzed so that public health officials and policymakers can respond swiftly and efficiently. Dr. Robert Gongora, a digital health specialist who has led implementation of the Zimbabwe Ministry of Health and Child Care (MoHCC) Electronic Health Records (EHR) system since 2017, commends the seamless flow of patient information. 'With more and more connectivity, we begin to learn immediately what's happening in that area because the moment we receive the information, we plan for that client ahead of arrival,' he says. Dr. Justice Mudavanhu, National Coordinator for Non-Communicable Diseases in the MoHCC, says the Ministry's head office uses VHW-submitted data to map the country's response to the growing incidence of childhood NCDs. 'In the program, we have technical experts who apply evidence-based interventions that help us to develop guidelines, standard operating procedures, algorithms and strategies for chronic diseases in children,' he said during a recent tour of rural Zimbabwe. Digital tools help identify and map disease incidence for better intervention 'There are systems at community level, at health facility level, and, as you go up, there are non-location-specific systems that enable data visualization. When we know what we are facing, we can target and measure our interventions better,' Dr. Mudavanhu adds. 'It's better not to shoot in the dark, especially where resource allocation is concerned.' We call them 'Digital Health Workers.' — Dr. Robert Gongora, Zimbabwe Ministry of Health and Child Care Equitable access to health care requires decision-making based on accurate and timely data. Authorities see vital interlinkages between the MoHCC digitization program and UNICEF's support for capacity building of the public health system. UNICEF, with the support of partners, is helping the MoHCC revolutionize community-based primary health care to strengthen NCD diagnosis, prevention and treatment within primary health care and referral facilities. Dr. Gongora suggests the title 'Village Health Worker' is outdated. Instead, he says, they should be called 'Digital Health Workers.' This vital work is made possible by a donation from Eli Lilly and Company (Lilly) to UNICEF USA. UNICEF is strengthening health systems and preventing, detecting and treating NCDs for children and adolescents in Bangladesh, Malawi, Nepal, India, the Philippines and Zimbabwe. © Copyright The Zimbabwean. All rights reserved. Provided by SyndiGate Media Inc. (
The National
3 days ago
- The National
UAE floating hospital brings Eid joy to Gaza patients
The UAE floating hospital in the Egyptian city of Al Arish held an event for children and patients from Gaza to mark Eid Al Adha, offering a moment of relief and celebration amid the trauma of war. Organised by medical staff, volunteers and support teams, the event featured face painting, games and the distribution of Eid gifts to patients and their families. The initiative aimed to provide psychological support, rehabilitative therapy and lift the spirits of those receiving care aboard the hospital vessel. 'The initiative is a testament to the hospital's humanitarian message to boost morality and happiness for patients and their families onboard of the vessel,' said Dr Omran Mohammed Alefari, director of the UAE floating hospital. 'It is important to provide a comprehensive medical and supportive environment for the patients, especially in such days.' The 100-bed floating hospital set sail from the UAE in February last year and docked in Al Arish port in Egypt as part of Operation Gallant Knight 3. Docked at the Egyptian port of Al Arish, it receives patients through the Rafah border crossing and is part of the broader humanitarian effort ordered by UAE President Sheikh Mohamed - serving as a lifeline for Palestinians affected by the conflict. Its humanitarian efforts are part of the UAE's mission to ease the suffering of the injured and sick amid the dire circumstances faced by Palestinians in Gaza. The hospital has provided medical services to thousands of patients since the launch of its services for Palestinian people. It has also performed more than 3,600 surgical procedures across specialities, provided physical therapy services to approximately 9,500 cases and fitted 23 prosthetic limbs for patients. The hospital was established by the UAE's Ministry of Defence, the Department of Health Abu Dhabi and the Abu Dhabi Ports Authority group, and includes about 100 medical and administrative staff specialising in anaesthesia, general surgery, orthopaedics and emergency services.
